Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
3.150
+0.610 (24.02%)
Mar 23, 2026, 4:00 PM EDT - Market closed

Serina Therapeutics Revenue

Serina Therapeutics had revenue of $116.00K in the twelve months ending September 30, 2025, down -96.33% year-over-year. In the year 2024, Serina Therapeutics had annual revenue of $56.00K, down -98.22%.

Revenue (ttm)
$116.00K
Revenue Growth
-96.33%
P/S Ratio
281.31
Revenue / Employee
$8,923
Employees
13
Market Cap
33.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202456.00K-3.10M-98.22%
Dec 31, 20233.15M3.12M9,173.53%
Dec 31, 202234.00K-110.00K-76.39%
Dec 31, 2021144.00K-217.00K-60.11%
Dec 31, 2020361.00K-1.37M-79.11%
Dec 31, 20191.73M332.00K23.78%
Dec 31, 20181.40M-8.00K-0.57%
Dec 31, 20171.40M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cue Biopharma27.47M
Barinthus Biotherapeutics14.97M
Kyntra Bio6.44M
IGC Pharma1.11M
Exicure500.00K
Hyperion DeFi345.32K
Outlook Therapeutics205.70K
Revenue Rankings